NPF New York Soirée Raises Nearly $500,000 for Psoriatic Disease Research

By AI, Created 4:27 PM UTC, May 18, 2026, /AGP/ – The National Psoriasis Foundation brought together more than 225 supporters in New York on April 16 and raised nearly $500,000 for psoriatic disease research and support. The money will help fund earlier diagnosis tools, expand treatment options and advance the organization’s mission to improve life for more than 8 million people in the U.S. living with the disease.

Why it matters: - The fundraiser will support research and services for more than 8 million people in the U.S. living with psoriatic disease. - The event’s proceeds will help fund earlier diagnostic tools for psoriatic arthritis, expand treatment options and support the push toward a cure. - The evening also helps sustain education and advocacy efforts for patients and families affected by psoriasis and psoriatic arthritis.

What happened: - The National Psoriasis Foundation hosted its annual New York Soirée on April 16, 2026, at SECOND in New York. - More than 225 supporters, advocates and leaders in health care and industry attended. - The event raised nearly $500,000 for the foundation’s mission. - Leah M. Howard, J.D., NPF president and CEO, said the community is accelerating progress and bringing hope to millions of people living with psoriatic disease.

The details: - NPF honored Matthew Kiselica with the Excellence in Leadership & Volunteerism Award. - NPF honored James Krueger, M.D., PhD, with the Lifetime Achievement Award. - The foundation recognized both honorees for compassion, expertise and commitment to the psoriatic disease community and beyond. - Presenting sponsor Johnson & Johnson backed the evening. - Lilly supported the event as a Cures Sponsor. - Novartis, NYU Langone Health and Organon served as Progress Sponsors. - The foundation said sponsor support helps fuel research, expand educational resources and provide critical support to patients and families. - Learn more about the National Psoriasis Foundation

Between the lines: - The soirée shows how patient advocacy groups increasingly depend on a mix of philanthropy, corporate sponsorship and community turnout to fund research priorities. - The emphasis on earlier diagnosis and expanded treatment options points to gaps that remain in psoriatic disease care. - The event also functioned as a public marker of momentum for a community that is trying to turn awareness into measurable medical progress.

What’s next: - NPF will use the funds to advance research initiatives and support its broader mission. - The foundation is likely to keep emphasizing early detection, more treatment options and long-term efforts to cure psoriatic disease. - Future fundraising events will remain important to sustaining that work.

The bottom line: - NPF turned a single-night gala into nearly $500,000 for research, advocacy and patient support, underscoring both the need and the community backing behind the fight against psoriatic disease.